Literature DB >> 26160184

PD-L1 blockade: rejuvenating T cells in CLL.

Arnon P Kater1, Gerritje J W van der Windt1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26160184     DOI: 10.1182/blood-2015-05-638338

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  Impact of mutational variant allele frequency on prognosis in myelodysplastic syndromes.

Authors:  Lingxu Jiang; Lu Wang; Chuying Shen; Shuanghong Zhu; Wei Lang; Yingwan Luo; Hua Zhang; Wenli Yang; Yueyuan Han; Liya Ma; Yanling Ren; Xinping Zhou; Chen Mei; Li Ye; Weilai Xu; Haiyang Yang; Chenxi Lu; Jie Jin; Hongyan Tong
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

2.  Suppression of Glut1 and Glucose Metabolism by Decreased Akt/mTORC1 Signaling Drives T Cell Impairment in B Cell Leukemia.

Authors:  Peter J Siska; Gerritje J W van der Windt; Rigel J Kishton; Sivan Cohen; William Eisner; Nancie J MacIver; Arnon P Kater; J Brice Weinberg; Jeffrey C Rathmell
Journal:  J Immunol       Date:  2016-08-10       Impact factor: 5.422

Review 3.  'Trained immunity': consequences for lymphoid malignancies.

Authors:  Wendy B C Stevens; Mihai G Netea; Arnon P Kater; Walter J F M van der Velden
Journal:  Haematologica       Date:  2016-11-10       Impact factor: 9.941

4.  Rapamycin and hydroxychloroquine combination alters macrophage polarization and sensitizes glioblastoma to immune checkpoint inhibitors.

Authors:  Sanford P C Hsu; Yi-Ching Chen; Hsin-Chien Chiang; Yi-Chun Huang; Cheng-Chung Huang; Hsin-Ell Wang; Yu-Shang Wang; Kwan-Hwa Chi
Journal:  J Neurooncol       Date:  2020-02-04       Impact factor: 4.130

5.  Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity.

Authors:  Sara Verdura; Elisabet Cuyàs; Eric Cortada; Joan Brunet; Eugeni Lopez-Bonet; Begoña Martin-Castillo; Joaquim Bosch-Barrera; José Antonio Encinar; Javier A Menendez
Journal:  Aging (Albany NY)       Date:  2020-01-04       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.